Which patients diagnosed with community-acquired pneumonia (CAP) are suitable for outpatient treatment rather than hospital admission?
Patients who may be suitable for outpatient treatment can be identified using severity of illness scores and prognostic models, such as the Pneumonia Severity Index (PSI) and CURB-65.
This question was addressed in a 1997 study evaluating how treatment decisions could be standardized with a prognostic model of illness severity.
1 Using a derivation cohort of 14,199 inpatients with CAP, the authors identified 20 factors independently associated with mortality, each assigned point values based on the magnitude of association. This model, known as the PSI, produced five risk classes and was then tested on two validation cohorts consisting mostly of inpatients with a small cohort of outpatients (
Table 14.1). Mortality did not differ within risk classes. For example, mortality ranged from 0.1% to 0.4% (class I), 0.6% to 0.7% (class II), and 0.9% to 2.8% (class III) (
P > .05 for all).
Given barriers to the use of PSI (e.g., numerous variables and need for time-intensive calculation), a 2003 cohort study sought to derive a simpler model.
2 Based on British Thoracic Society (BTS) guidelines previously validated to identify patients with severe CAP, a derivation cohort of 1068 patients hospitalized with CAP was used to identify five variables independently associated with mortality. From these data, authors derived the CURB-65 model, which stratified patients into three classes according to mortality risk (
Table 14.1). CURB-65 was then applied to an inpatient validation cohort and demonstrated no observed differences in mortality within risk classes between the derivation and validation cohorts. Despite the benefit of its simplicity for clinical use, the CURB-65 was derived and validated among inpatients only, potentially limiting its applicability in the outpatient setting.
While not substitutes for clinical judgment, Infectious Diseases Society of America (IDSA) guidelines support the use of these prognostic models for guiding risk stratification and identifying patients at the
lowest risk of mortality who may be appropriate for outpatient treatment (strong recommendation; level I evidence).
3
Only gold members can continue reading.
Log In or
Register to continue
Related
Full access? Get Clinical Tree